Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

被引：702

作者：

Blass, Eryn ^{[1
]}

Ott, Patrick A. ^{[1
,2
,3
,4
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA

[3] Harvard Med Sch, Boston, MA 02115 USA

[4] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2021年 / 18卷 / 04期

关键词：

CD4(+) T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; EXOME ANALYSIS REVEALS; PD-1; BLOCKADE; OPTIMAL INDUCTION; CTLA-4; CD4+T CELLS; MEMORY; MELANOMA; LANDSCAPE;

D O I：

10.1038/s41571-020-00460-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Within the past decade, the field of immunotherapy has revolutionized the treatment of many cancers with the development and regulatory approval of various immune-checkpoint inhibitors and chimeric antigen receptor T cell therapies in diverse indications. Another promising approach to cancer immunotherapy involves the use of personalized vaccines designed to trigger de novo T cell responses against neoantigens, which are highly specific to tumours of individual patients, in order to amplify and broaden the endogenous repertoire of tumour-specific T cells. Results from initial clinical studies of personalized neoantigen-based vaccines, enabled by the availability of rapid and cost-effective sequencing and bioinformatics technologies, have demonstrated robust tumour-specific immunogenicity and preliminary evidence of antitumour activity in patients with melanoma and other cancers. Herein, we provide an overview of the complex process that is necessary to generate a personalized neoantigen vaccine, review the types of vaccine-induced T cells that are found within tumours and outline strategies to enhance the T cell responses. In addition, we discuss the current status of clinical studies testing personalized neoantigen vaccines in patients with cancer and considerations for future clinical investigation of this novel, individualized approach to immunotherapy.

引用

页码：215 / 229

页数：15

共 146 条

[1] Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination [J].

Aarntzen, Erik H. J. G. ;

De Vries, I. Jolanda M. ;

Lesterhuis, W. Joost ;

Schuurhuis, Danita ;

Jacobs, Joannes F. M. ;

Bol, Kalijn ;

Schreibelt, Gerty ;

Mus, Roel ;

De Wilt, Johannes H. W. ;

Haanen, John B. A. G. ;

Schadendorf, Dirk ;

Croockewit, Alexandra ;

Blokx, Willeke A. M. ;

Van Rossum, Michelle M. ;

Kwok, William W. ;

Adema, Gosse J. ;

Punt, Cornelis J. A. ;

Figdor, Carl G. .

CANCER RESEARCH, 2013, 73 (01) :19-29

[2] Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction [J].

Abelin, Jennifer G. ;

Harjanto, Dewi ;

Malloy, Matthew ;

Suri, Prerna ;

Colson, Tyler ;

Goulding, Scott P. ;

Creech, Amanda L. ;

Serrano, Lia R. ;

Nasir, Gibran ;

Nasrullah, Yusuf ;

McGann, Christopher D. ;

Velez, Diana ;

Ting, Ying S. ;

Poran, Asaf ;

Rothenberg, Daniel A. ;

Chhangawala, Sagar ;

Rubinsteyn, Alex ;

Hammerbacher, Jeff ;

Gaynor, Richard B. ;

Fritsch, Edward F. ;

Greshock, Joel ;

Oslund, Rob C. ;

Barthelme, Dominik ;

Addona, Terri A. ;

Arleta, Christina M. ;

Rooney, Michael S. .

IMMUNITY, 2019, 51 (04) :766-+

[3] Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction [J].

Abelin, Jennifer G. ;

Keskin, Derin B. ;

Sarkizova, Siranush ;

Hartigan, Christina R. ;

Zhang, Wandi ;

Sidney, John ;

Stevens, Jonathan ;

Lane, William ;

Zhang, Guang Lan ;

Eisenhaure, Thomas M. ;

Clauser, Karl R. ;

Hacohen, Nir ;

Rooney, Michael S. ;

Carr, Steven A. ;

Wu, Catherine J. .

IMMUNITY, 2017, 46 (02) :315-326

[4] Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity [J].

Ahmadzadeh, Mojgan ;

Pasetto, Anna ;

Jia, Li ;

Deniger, Drew C. ;

Stevanovic, Sanja ;

Robbins, Paul F. ;

Rosenberg, Steven A. .

SCIENCE IMMUNOLOGY, 2019, 4 (31)

[5] The opposing roles of CD4+ T cells in anti-tumour immunity [J].

Ahrends, Tomasz ;

Borst, Jannie .

IMMUNOLOGY, 2018, 154 (04) :582-592

[6] CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness [J].

Ahrends, Tomasz ;

Spanjaard, Aldo ;

Pilzecker, Bas ;

Babala, Nikolina ;

Bovens, Astrid ;

Xiao, Yanling ;

Jacobs, Heinz ;

Borst, Jannie .

IMMUNITY, 2017, 47 (05) :848-+

[7] Signatures of mutational processes in human cancer [J].

Alexandrov, Ludmil B. ;

Nik-Zainal, Serena ;

Wedge, David C. ;

Aparicio, Samuel A. J. R. ;

Behjati, Sam ;

Biankin, Andrew V. ;

Bignell, Graham R. ;

Bolli, Niccolo ;

Borg, Ake ;

Borresen-Dale, Anne-Lise ;

Boyault, Sandrine ;

Burkhardt, Birgit ;

Butler, Adam P. ;

Caldas, Carlos ;

Davies, Helen R. ;

Desmedt, Christine ;

Eils, Roland ;

Eyfjord, Jorunn Erla ;

Foekens, John A. ;

Greaves, Mel ;

Hosoda, Fumie ;

Hutter, Barbara ;

Ilicic, Tomislav ;

Imbeaud, Sandrine ;

Imielinsk, Marcin ;

Jaeger, Natalie ;

Jones, David T. W. ;

Jones, David ;

Knappskog, Stian ;

Kool, Marcel ;

Lakhani, Sunil R. ;

Lopez-Otin, Carlos ;

Martin, Sancha ;

Munshi, Nikhil C. ;

Nakamura, Hiromi ;

Northcott, Paul A. ;

Pajic, Marina ;

Papaemmanuil, Elli ;

Paradiso, Angelo ;

Pearson, John V. ;

Puente, Xose S. ;

Raine, Keiran ;

Ramakrishna, Manasa ;

Richardson, Andrea L. ;

Richter, Julia ;

Rosenstiel, Philip ;

Schlesner, Matthias ;

Schumacher, Ton N. ;

Span, Paul N. ;

Teague, Jon W. .

NATURE, 2013, 500 (7463) :415-+

[8] MHC-II neoantigens shape tumour immunity and response to immunotherapy [J].

Alspach, Elise ;

Lussier, Danielle M. ;

Miceli, Alexander P. ;

Kizhvatov, Ilya ;

DuPage, Michel ;

Luoma, Adrienne M. ;

Meng, Wei ;

Lichti, Cheryl F. ;

Esaulova, Ekaterina ;

Vomund, Anthony N. ;

Runci, Daniele ;

Ward, Jeffrey P. ;

Gubin, Matthew M. ;

Medrano, Ruan F. V. ;

Arthur, Cora D. ;

White, J. Michael ;

Sheehan, Kathleen C. F. ;

Chen, Alex ;

Wucherpfennig, Kai W. ;

Jacks, Tyler ;

Unanue, Emil R. ;

Artyomov, Maxim N. ;

Schreiber, Robert D. .

NATURE, 2019, 574 (7780) :696-+

[9] Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer [J].

Anagnostou, Valsamo ;

Smith, Kellie N. ;

Forde, Patrick M. ;

Niknafs, Noushin ;

Bhattacharya, Rohit ;

White, James ;

Zhang, Theresa ;

Adleff, Vilmos ;

Phallen, Jillian ;

Wali, Neha ;

Hruban, Carolyn ;

Guthrie, Violeta B. ;

Rodgers, Kristen ;

Naidoo, Jarushka ;

Kang, Hyunseok ;

Sharfman, William ;

Georgiades, Christos ;

Verde, Franco ;

Illei, Peter ;

Li, Qing Kay ;

Gabrielson, Edward ;

Brock, Malcolm V. ;

Zahnow, Cynthia A. ;

Baylin, Stephen B. ;

Scharpf, Robert B. ;

Brahmer, Julie R. ;

Karchin, Rachel ;

Pardoll, Drew M. ;

Velculescu, Victor E. .

CANCER DISCOVERY, 2017, 7 (03) :264-276

[10] Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification [J].

Andreatta, Massimo ;

Karosiene, Edita ;

Rasmussen, Michael ;

Stryhn, Anette ;

Buus, Soren ;

Nielsen, Morten .

IMMUNOGENETICS, 2015, 67 (11-12) :641-650

← 1 2 3 4 5 6 7 8 9 10 →